Last 27 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -5.60 | — | — | — | — | — | 0.80 | — | — | — | — | — | — | — | 82.38 | — | 82.43 | — | 77.28 | 20.10 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | +6.6% | — | — | — | — | — | — | |
| P/S Ratio | 0.35 | 0.30 | 0.31 | 0.45 | 0.54 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.10 | 1.03 | 2.05 | 2.36 | 4.85 | 3.20 | 5.03 | 4.71 | 8.55 | 11.35 |
| — | +563.4% | +626.3% | +1396.1% | +1715.6% | +57.6% | +13.9% | -69.4% | -97.1% | -98.6% | -98.4% | -98.0% | -67.7% | -59.2% | -49.8% | -43.3% | -71.8% | -60.1% | -18.7% | +20.0% | +21.3% | |
| P/B Ratio | 1.75 | 1.47 | 1.61 | 2.12 | 2.90 | 0.19 | 0.18 | 0.18 | 0.19 | 0.15 | 0.20 | 0.51 | 6.74 | 8.89 | 6.86 | 11.33 | 7.53 | 6.92 | 5.54 | 7.54 | 11.69 |
| — | +664.5% | +791.5% | +1064.4% | +1419.7% | +28.6% | -8.1% | -64.1% | -97.2% | -98.3% | -97.1% | -95.5% | -10.5% | +28.5% | +23.9% | +50.1% | -35.6% | — | -94.2% | — | — | |
| P/FCF | 4.60 | 1.45 | 15.30 | — | 3.21 | 0.37 | 0.31 | 1.13 | 0.16 | 0.27 | 0.82 | — | — | 13.27 | 13.44 | — | — | — | — | — | — |
| — | +293.5% | +4830.6% | — | +1924.0% | +35.7% | -62.1% | — | — | -98.0% | -93.9% | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 10.84 | 11.70 | 7.09 | 19.78 | 14.66 | 19.65 | 16.49 | — | — | — | — | — | — | — | — | — | 160.06 | 291.87 | 615.93 | — | 386.67 |
| — | -40.5% | -57.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | -58.6% | — | — | — | — | |
| EV / EBIT | — | — | 12.97 | — | 51.63 | — | 1.95 | — | — | — | 25.17 | 40.10 | — | — | 71.35 | — | 60.17 | 186.69 | 48.90 | 16.45 | — |
| — | — | +565.8% | — | — | — | -92.3% | — | — | — | -64.7% | — | — | — | +45.9% | — | — | — | — | -91.1% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.3% | 68.1% | 68.4% | 68.4% | 64.4% | 64.6% | 62.8% | 69.8% | 62.7% | 51.6% | 45.2% | 59.4% | 47.2% | -12.9% | 57.8% | 62.7% | 66.4% | 69.1% | 67.6% | 67.5% | 72.9% |
| — | +5.4% | +8.9% | -2.0% | +2.7% | +25.2% | +39.0% | +17.5% | +32.9% | +500.3% | -21.8% | -5.3% | -29.0% | -118.6% | -14.6% | -7.1% | -8.9% | +2.2% | -4.8% | +1.1% | +19.8% | |
| Operating Margin | -6.9% | 7.2% | 5.0% | -2.8% | 0.2% | -8.8% | -3.5% | -17.3% | -8.6% | -27.3% | -24.4% | -20.9% | -19.0% | -84.3% | -11.2% | -20.1% | -3.8% | -4.9% | -4.9% | -18.6% | -9.3% |
| — | +181.8% | +243.4% | +83.9% | +102.3% | +67.6% | +85.9% | +17.2% | +54.8% | +67.6% | -118.1% | -4.0% | -394.3% | -1619.2% | -130.5% | -8.0% | +58.6% | +38.8% | +87.7% | -470.9% | +25.5% | |
| Net Margin | -3.2% | -1.3% | -3.7% | -10.2% | -9.8% | -15.6% | 25.2% | -14.5% | -12.4% | -23.2% | 0.2% | -0.8% | -9.7% | -75.8% | 2.9% | -23.5% | 3.9% | -0.1% | 6.1% | 41.7% | -22.2% |
| — | +91.7% | -114.7% | +29.9% | +20.5% | +32.7% | +11205.6% | -1639.6% | -27.4% | +69.4% | -92.2% | +96.4% | -349.8% | -82990.4% | -53.1% | -156.3% | +117.5% | +100.0% | +102.9% | +705.7% | -12.4% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -16.9% | -1.6% | -4.8% | -11.4% | -12.8% | -15.8% | 32.8% | -20.6% | -18.5% | -28.4% | 0.3% | -1.1% | -12.6% | -58.6% | 2.2% | -12.9% | 1.8% | -0.0% | 1.8% | 9.8% | -21.6% |
| — | +89.8% | -114.7% | +45.0% | +31.0% | +44.3% | +10669.5% | -1764.0% | -47.1% | +51.6% | -86.0% | +91.4% | -801.3% | -221154.7% | +19.4% | -231.8% | +108.3% | — | +100.2% | — | — | |
| ROA | -1.6% | -0.2% | -0.6% | -1.4% | -1.6% | -2.2% | 3.3% | -1.5% | -1.5% | -2.6% | 0.0% | -0.1% | -1.0% | -7.5% | 0.3% | -2.0% | 0.4% | -0.0% | 0.5% | 2.6% | -1.6% |
| — | +90.6% | -116.7% | +8.7% | -8.3% | +15.8% | +12735.0% | -1838.9% | -50.8% | +65.2% | -92.3% | +96.2% | -373.1% | -106390.0% | -35.8% | -177.9% | +123.2% | +100.0% | +101.1% | +281.8% | +53.5% | |
| ROIC | -6.8% | 1.8% | 1.2% | -0.6% | 0.1% | -2.0% | -0.8% | -3.7% | -2.1% | -5.8% | -5.6% | -4.3% | -4.8% | -19.0% | -2.7% | -3.6% | -0.8% | -1.1% | -1.5% | -5.6% | -72.1% |
| — | +187.6% | +246.0% | +82.7% | +102.7% | +65.2% | +85.0% | +14.7% | +57.1% | +69.5% | -108.7% | -19.3% | -475.1% | -1662.5% | -82.5% | +35.3% | +98.8% | — | +96.6% | -652.6% | -3549.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 6.20 | 4.74 | 6.60 | 6.65 | 6.20 | 5.77 | 5.09 | 12.32 | 10.97 | 9.52 | 8.20 | 10.80 | 12.67 | 8.36 | 4.65 | 5.10 | 4.50 | 2.91 | 2.13 | 2.19 | 2.47 |
| — | -17.9% | +29.7% | -46.0% | -43.4% | -39.3% | -37.9% | +14.1% | -13.4% | +13.8% | +76.6% | +112.0% | +181.5% | +187.7% | +118.3% | +133.1% | +82.3% | — | — | — | — | |
| Debt / EBITDA | 83.30 | 52.86 | 41.51 | 103.85 | 68.70 | 172.97 | 139.48 | — | — | — | — | — | — | — | — | — | 333.98 | 472.84 | 982.56 | — | 341.61 |
| — | -69.4% | -70.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | -2.2% | — | — | — | — | |
| Current Ratio | 1.66 | 2.89 | 1.76 | 1.79 | 1.66 | 4.98 | 5.15 | 7.47 | 7.00 | 6.56 | 6.49 | 6.57 | 6.07 | 5.86 | 9.28 | 10.35 | 10.92 | 11.68 | 11.44 | 14.25 | 13.09 |
| — | -42.0% | -65.9% | -76.1% | -76.3% | -24.1% | -20.7% | +13.7% | +15.3% | +11.9% | -30.0% | -36.5% | -44.4% | -49.8% | -18.9% | -27.4% | -16.6% | -27.6% | +158.9% | +790.1% | +585.4% | |
| Quick Ratio | 1.40 | 2.23 | 1.48 | 1.48 | 1.40 | 4.07 | 4.15 | 6.43 | 5.99 | 5.57 | 5.47 | 5.55 | 5.28 | 5.27 | 7.98 | 8.66 | 9.39 | 10.34 | 10.59 | 13.57 | 12.63 |
| — | -45.4% | -64.4% | -76.9% | -76.6% | -26.8% | -24.0% | +15.9% | +13.4% | +5.7% | -31.5% | -35.9% | -43.8% | -49.1% | -24.6% | -36.2% | -25.6% | -33.5% | +177.6% | +1118.6% | +988.6% | |
| Interest Coverage | 0.69 | 0.79 | 0.77 | -0.07 | 0.25 | -0.69 | 5.52 | -2.68 | -3.76 | -5.62 | 0.94 | 0.56 | -1.62 | -19.42 | 1.34 | -6.00 | 1.76 | 0.73 | 2.99 | — | -3.66 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 27 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SKIN stock.
SkinHealth Systems Inc.'s current P/E is -5.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
SkinHealth Systems Inc.'s current operating margin is -6.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking SkinHealth Systems Inc.'s business trajectory between earnings reports.